These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1347348)

  • 1. Effect of high-dose intravenous immunoglobulin therapy on blood rheology.
    Reinhart WH; Berchtold PE
    Lancet; 1992 Mar; 339(8794):662-4. PubMed ID: 1347348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.
    Dalakas MC
    Neurology; 1994 Feb; 44(2):223-6. PubMed ID: 8309562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure.
    Bentley P; Rosso M; Sadnicka A; Israeli-Korn S; Laffan M; Sharma P
    J Clin Pharm Ther; 2012 Jun; 37(3):286-90. PubMed ID: 21767284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
    Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
    Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.
    Hefer D; Jaloudi M
    Ann Hematol; 2004 Oct; 83(10):661-5. PubMed ID: 15309520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immunoglobulin administration on blood rheology in patients with septic shock.
    Madl C; Koppensteiner R; Wendelin B; Lenz K; Kramer L; Grimm G; Kranz A; Schneeweiss B; Ehringer H
    Circ Shock; 1993 Aug; 40(4):264-7. PubMed ID: 8375028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.
    Steinberger BA; Ford SM; Coleman TA
    Am J Hematol; 2003 Jun; 73(2):97-100. PubMed ID: 12749010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders.
    Kowal P; Zmyślony A
    Clin Hemorheol Microcirc; 2008; 40(3):229-34. PubMed ID: 19029646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and treatment responses of X-linked thrombocytopenia].
    Zhang X; Liu D; Luo G; Du H; Wu J; Zou L; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):890-5. PubMed ID: 25619343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
    Yildiz I; Ozdemir N; Celkan T; Soylu S; Karaman S; Canbolat A; Dogru O; Erginoz E; Apak H
    Pediatr Hematol Oncol; 2015; 32(6):406-14. PubMed ID: 26154620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin, blood viscosity and myocardial infarction.
    Fisman DN; Smilovitch M
    Can J Cardiol; 1997 Aug; 13(8):775-7. PubMed ID: 9284845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations.
    Wolberg AS; Kon RH; Monroe DM; Hoffman M
    Am J Hematol; 2000 Sep; 65(1):30-4. PubMed ID: 10936860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How blood viscosity influences changes in circulation during pregnancy?
    Sakai K; Maeda H; Tsukimori K; Nagata H; Koyanagi T; Nakano H
    Fukuoka Igaku Zasshi; 1992 Aug; 83(8):328-32. PubMed ID: 1398428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of sex hormones on hemorrheology and plasma proteins during the menstrual cycle].
    Solerte SB; Fioravanti M; Magri F; Spinillo A; Guaschino S; Ferrari E
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):139-42. PubMed ID: 1767163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].
    Ehrly M
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):131-8. PubMed ID: 1767162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Doppler velocimetry evaluation of intestinal blood flow characteristics in neonates receiving intravenous immunoglobulin therapy: a prospective observational study.
    Louis D; Patil S; Saini SS; Kumar P
    Indian J Pediatr; 2015 Jun; 82(6):553-7. PubMed ID: 25598445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
    Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.